Michael A. Heneghan

1.8k total citations
26 papers, 1.2k citations indexed

About

Michael A. Heneghan is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Michael A. Heneghan has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 20 papers in Epidemiology and 12 papers in Rheumatology. Recurrent topics in Michael A. Heneghan's work include Liver Diseases and Immunity (23 papers), Liver Disease Diagnosis and Treatment (19 papers) and Systemic Lupus Erythematosus Research (10 papers). Michael A. Heneghan is often cited by papers focused on Liver Diseases and Immunity (23 papers), Liver Disease Diagnosis and Treatment (19 papers) and Systemic Lupus Erythematosus Research (10 papers). Michael A. Heneghan collaborates with scholars based in United Kingdom, United States and Portugal. Michael A. Heneghan's co-authors include Maria Serena Longhi, Bernard Portmann, Ian G. McFarlane, Andrew D. Yeoman, Sumita Verma, Alastair D. Smith, Thawab Al–Chalabi, Rodrigo Liberal, Diego Vergani and Giorgina Mieli‐Vergani and has published in prestigious journals such as The Lancet, Hepatology and Gut.

In The Last Decade

Michael A. Heneghan

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Heneghan United Kingdom 20 991 868 325 253 176 26 1.2k
Paolo Montalto Italy 9 676 0.7× 495 0.6× 311 1.0× 93 0.4× 73 0.4× 17 887
J.C. Trinchet France 11 697 0.7× 717 0.8× 109 0.3× 123 0.5× 36 0.2× 26 1.0k
Themistoklis Vassiliadis Greece 17 371 0.4× 427 0.5× 117 0.4× 83 0.3× 65 0.4× 28 657
M. Koulentaki Greece 16 391 0.4× 374 0.4× 151 0.5× 56 0.2× 70 0.4× 43 671
Giovanni Tritto Italy 13 422 0.4× 377 0.4× 180 0.6× 42 0.2× 54 0.3× 32 661
Toshikazu Masumoto Japan 14 324 0.3× 346 0.4× 204 0.6× 61 0.2× 194 1.1× 39 799
Antonio Linares Spain 8 523 0.5× 521 0.6× 172 0.5× 79 0.3× 25 0.1× 10 766
Jorge Findor Argentina 12 410 0.4× 361 0.4× 104 0.3× 119 0.5× 37 0.2× 33 652
A Lobo-Yeo United Kingdom 13 335 0.3× 284 0.3× 98 0.3× 108 0.4× 143 0.8× 21 563
Sara Cmet Italy 15 559 0.6× 666 0.8× 54 0.2× 86 0.3× 71 0.4× 35 1.0k

Countries citing papers authored by Michael A. Heneghan

Since Specialization
Citations

This map shows the geographic impact of Michael A. Heneghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Heneghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Heneghan more than expected).

Fields of papers citing papers by Michael A. Heneghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Heneghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Heneghan. The network helps show where Michael A. Heneghan may publish in the future.

Co-authorship network of co-authors of Michael A. Heneghan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Heneghan. A scholar is included among the top collaborators of Michael A. Heneghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Heneghan. Michael A. Heneghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leighton, Jessica, Anna Goulding, Emma Culver, et al.. (2022). Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging Stigma. Digestive Diseases and Sciences. 68(1). 87–97. 6 indexed citations
2.
Huang, Zhenlin, et al.. (2022). Systematic review with meta‐analysis: outcomes of pregnancy in patients with autoimmune hepatitis. Alimentary Pharmacology & Therapeutics. 55(11). 1368–1378. 11 indexed citations
3.
Liberal, Rodrigo, Ynto S. de Boer, & Michael A. Heneghan. (2021). Established and novel therapeutic options for autoimmune hepatitis. ˜The œLancet. Gastroenterology & hepatology. 6(4). 315–326. 19 indexed citations
4.
Ma, Yun, Haibin Su, Muhammed Yüksel, et al.. (2021). Human Leukocyte Antigen Profile Predicts Severity of Autoimmune Liver Disease in Children of European Ancestry. Hepatology. 74(4). 2032–2046. 32 indexed citations
5.
Graham, Jonathon J., Maria Serena Longhi, & Michael A. Heneghan. (2021). T helper cell immunity in pregnancy and influence on autoimmune disease progression. Journal of Autoimmunity. 121. 102651–102651. 38 indexed citations
6.
Halliday, Neil, Jessica Dyson, Douglas Thorburn, Ansgar W. Lohse, & Michael A. Heneghan. (2020). Review article: experimental therapies in autoimmune hepatitis. Alimentary Pharmacology & Therapeutics. 52(7). 1134–1149. 20 indexed citations
7.
Giorgio, Angelo Di, Nedim Hadžić, Anil Dhawan, et al.. (2020). Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome. The Journal of Pediatrics. 218. 121–129.e3. 21 indexed citations
8.
Fisher, Holly, Deborah Stocken, Stephen Rice, et al.. (2018). The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility. Hepatology. 68(4). 1487–1497. 50 indexed citations
9.
Grant, Charlotte R., Beth Holder, Rodrigo Liberal, et al.. (2017). Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis. Clinical & Experimental Immunology. 189(1). 71–82. 21 indexed citations
10.
Liberal, Rodrigo, Ynto S. de Boer, Raúl J. Andrade, et al.. (2016). Expert clinical management of autoimmune hepatitis in the real world. Alimentary Pharmacology & Therapeutics. 45(5). 723–732. 60 indexed citations
11.
Lawrence, David S., et al.. (2016). Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long‐term outcomes. Liver International. 37(3). 449–457. 48 indexed citations
12.
Liberal, Rodrigo, Charlotte R. Grant, Yun Ma, et al.. (2016). CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease. Journal of Autoimmunity. 72. 102–112. 45 indexed citations
13.
Holder, Beth, Charlotte R. Grant, Rodrigo Liberal, et al.. (2014). Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2. Journal of Autoimmunity. 53. 26–32. 28 indexed citations
14.
Heneghan, Michael A., Andrew D. Yeoman, Sumita Verma, Alastair D. Smith, & Maria Serena Longhi. (2013). Autoimmune hepatitis. The Lancet. 382(9902). 1433–1444. 200 indexed citations
15.
Heneghan, Michael A., et al.. (2012). Current concepts in the diagnosis and management of autoimmune hepatitis. Frontline Gastroenterology. 4(1). 2–11. 2 indexed citations
16.
Zen, Yoh, Tassos Grammatikopoulos, Michael A. Heneghan, et al.. (2012). Sclerosing Cholangitis With Granulocytic Epithelial Lesion. The American Journal of Surgical Pathology. 36(10). 1555–1561. 20 indexed citations
17.
Al–Chalabi, Thawab, James A. Underhill, Bernard Portmann, Ian G. McFarlane, & Michael A. Heneghan. (2008). Effects of Serum Aspartate Aminotransferase Levels in Patients With Autoimmune Hepatitis Influence Disease Course and Outcome. Clinical Gastroenterology and Hepatology. 6(12). 1389–1395. 36 indexed citations
18.
19.
Heneghan, Michael A., et al.. (2002). Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Gut. 50(5). 713–717. 75 indexed citations
20.
Heneghan, Michael A., Bernard Portmann, Roger Williams, et al.. (2001). Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology. 34(3). 464–470. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Montalto Breakdown of academic impact, for papers by J.C. Trinchet Breakdown of academic impact, for papers by Themistoklis Vassiliadis Breakdown of academic impact, for papers by M. Koulentaki Breakdown of academic impact, for papers by Giovanni Tritto Breakdown of academic impact, for papers by Toshikazu Masumoto Breakdown of academic impact, for papers by Antonio Linares Breakdown of academic impact, for papers by Jorge Findor Breakdown of academic impact, for papers by A Lobo-Yeo Breakdown of academic impact, for papers by Sara Cmet
Rankless by CCL
2026